Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial

Recent data from the randomized SUSTAIN CSX trial could not confirm clinical benefits from perioperative selenium treatment in high-risk cardiac surgery patients. Underlying reasons may involve inadequate bios...

Source: Intensive Care Medicine Experimental - December 8, 2023 Category: Surgery Authors: Quirin Notz, Daren K. Heyland, Zheng-Yii Lee, Johannes Menger, Johannes Herrmann, Thilo S. Chillon, Stephen Fremes, Siamak Mohammadi, Gunnar Elke, C. David Mazer, Aileen Hill, Markus Velten, Sascha Ott, Maren Kleine-Brueggeney, Patrick Meybohm, Lutz Schom Tags: Research Articles Source Type: research